Clinical trials recruiting for Metastatic Esophageal Carcinoma
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Combination of MVF-HER-2 (597-626) and MVF-HER-2 (266-296) emulsified with ISA 51 | 1 |
| Olanzapine | 1 |
| PRMT5 Inhibitor BMS-986504 | 1 |
| Pemetrexed | 1 |
| Radiation Therapy (RT) | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Arizona | 1 |
| California | 1 |
| Florida | 1 |
| Illinois | 1 |
| Indiana | 1 |
| Minnesota | 1 |
| Oregon | 1 |
Top cities
Self-screener
Recruiting trials
- BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion
- HER-2 B Cell Peptide Vaccine
- Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
- Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
- Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
Related conditions
Trials recruiting for Metastatic Esophageal Carcinoma often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Metastatic Esophageal Carcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.